Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

67.04
+0.36000.54%
Post-market: 67.040.00000.00%16:10 EDT
Volume:253.41K
Turnover:16.98M
Market Cap:3.42B
PE:21.31
High:67.68
Open:66.16
Low:65.96
Close:66.68
52wk High:110.67
52wk Low:64.29
Shares:51.00M
Float Shares:27.58M
Volume Ratio:0.92
T/O Rate:0.92%
Dividend:2.42
Dividend Rate:3.61%
EPS(TTM):3.15
EPS(LYR):3.00
ROE:32.55%
ROA:14.88%
PB:6.47
PE(LYR):22.34

Loading ...

Cohen & Steers Inc - CFO Raja Dakkuri to Resign Effective Oct 17, 2025

THOMSON REUTERS
·
Sep 16

Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst

Benzinga_recent_news
·
Sep 16

Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

GlobeNewswire
·
Sep 15

Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador

GlobeNewswire
·
Sep 15

CNS Pharmaceuticals Raised to Buy From Hold by Maxim Group

Dow Jones
·
Sep 12

CNS Pharmaceuticals upgraded to Buy from Hold at Maxim

TIPRANKS
·
Sep 12

Dr. Reddy’s Acquires STUGERON® Portfolio to Enhance CNS Offerings

TIPRANKS
·
Sep 11

Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225

GlobeNewswire
·
Sep 11

Press Release: Cohen & Steers Infrastructure Fund, Inc. Declares Distribution for October 2025

Dow Jones
·
Sep 11

Press Release: Cohen & Steers Infrastructure Fund, Inc. Announces Terms of Transferable Rights Offering

Dow Jones
·
Sep 11

Biotech Company Rapport Plunges 18.8% Following Completion of $250 Million Public Offering

Deep News
·
Sep 10

Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association

GlobeNewswire
·
Sep 10

Cohen & Steers Inc. Reports Increase in Assets Under Management to $90.4 Billion for August 2025

Reuters
·
Sep 10

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2025

THOMSON REUTERS
·
Sep 10

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

GlobeNewswire
·
Sep 09

Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

GlobeNewswire
·
Sep 09

Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025

GlobeNewswire
·
Sep 08

Cohen & Steers Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Sep 05

Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September

GlobeNewswire
·
Sep 05

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05